A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study

Cephalalgia

Volumn 34, Issue 7, 2014, Pages 523-532

  Stovner, Lars J ^a   Linde, Mattias ^a   Gravdahl, Gøril B ^a   Tronvik, Erling ^a   Aamodt, Anne H ^a,b   Sand, Trond ^a   Hagen, Knut ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Candesartan; clinical trial; migraine; prophylaxis; propranolol

Indexed keywords

CANDESARTAN; PROPRANOLOL; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; ANEMIA; ARTICLE; COGNITIVE DEFECT; COLD LIMB; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DIARRHEA; DIZZINESS; DRUG EFFICACY; EDEMA; EPISODIC MIGRAINE; EPISTAXIS; FAINTNESS; FATIGUE; FEMALE; HAIR LOSS; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; INTENTION TO TREAT ANALYSIS; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NAUSEA; OUTCOME ASSESSMENT; PAIN; PARESTHESIA; PROPHYLAXIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SLEEP DISORDER; SLOW RELEASE FORMULATION; SWEATING; THROAT DISEASE; TOOTH DISEASE; TRANSFORMED MIGRAINE; TREATMENT RESPONSE; TRIPLE BLIND PROCEDURE; URINARY TRACT INFECTION; VISUAL DISORDER; BIOLOGICAL MODEL; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; MIGRAINE; SECONDARY PREVENTION;

ADULT; BENZIMIDAZOLES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; MODELS, NEUROLOGICAL; PROPRANOLOL; SECONDARY PREVENTION; TETRAZOLES;

EID: 84900991550     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413515348     Document Type: Article

References (23)

1. Lancet. 2012 ; 380: 2053-2260
2. Stovner L, Andrée C. Impact of headache in Europe: A review for the Eurolight project. J Headache Pain. 2008 ; 9: 139-146
3. Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: The Eurolight project. Eur J Neurol. 2012 ; 19: 703-711
4. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 ; 68: 343-349 (Pubitemid 46184209)
5. Mathew N, Tfelt-Hansen P The headaches. 3 rd edn. Philadelphia: Lippincott Williams & Wilkins, 2005, pp. 433-440. Olesen JG Ramadan PJ Tfelt-Hansen NM, ed. Philadelphia: Lippincott Williams & Wilkins ; 2005: 433-440.
6. Tronvik E, Stovner LJ, Helde G, et al. Prophylactic treatment of migraine with an angiotensin II receptor blocker: A randomized controlled trial. JAMA. 2003 ; 289: 65-69 (Pubitemid 36026279)
7. Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012 ; 78: 1337-1345
8. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009 ; 16: 968-981
9. Stark RJ, Stark CD. Migraine prophylaxis. Med J Aust. 2008 ; 189: 283-288
10. Tfelt-Hansen P, Block G, Dahlöf C, et al. Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia. 2000 ; 20: 765-786 (Pubitemid 32154559)
11. Silberstein S, Tfelt-Hansen P, Dodick DW, et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia. 2008 ; 28: 484-495 (Pubitemid 351502554)
12. Piaggio G, Elbourne DR, Altman DG, et al. Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA. 2006 ; 295: 1152-1160 (Pubitemid 43352345)
13. Schrader H, Stovner LJ, Helde G, et al. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): Randomised, placebo controlled, crossover study. BMJ. 2001 ; 322: 19-22 (Pubitemid 32066251)
14. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev. 2004 ; CD003225 :
15. Bendtsen L, Mattsson P, Zwart JA, et al. Placebo response in clinical randomized trials of analgesics in migraine. Cephalalgia. 2003 ; 23: 487-490 (Pubitemid 37114968)
16. Senn SJ. Is the 'simple carry-over' model useful. Stat Med. 1992 ; 11: 715-726
17. Diener HC, Agosti R, Allais G, et al. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2007 ; 6: 1054-1062 (Pubitemid 350123606)
18. Wöber C, Wöber-Bingöl C, Koch G, et al. Long-term results of migraine prophylaxis with flunarizine and beta-blockers. Cephalalgia. 1991 ; 11: 251-256
19. Tronvik E, Wienecke T, Monstad I, et al. Randomised trial on episodic cluster headache with an angiotensin II receptor blocker. Cephalalgia. 2013 ; 33: 1026-1034
20. Diener HC, Gendolla A, Feuersenger A, et al. Telmisartan in migraine prophylaxis: A randomized, placebo-controlled trial. Cephalalgia. 2009 ; 29: 921-927
21. Owada K. Efficacy of candesartan in the treatment of migraine in hypertensive patients. Hypertens Res. 2004 ; 27: 441-446 (Pubitemid 38996935)
22. Charles JA, Jotkowitz S, Byrd LH. Prevention of migraine with olmesartan in patients with hypertension/prehypertension. Headache. 2006 ; 46: 503-507
23. Tronvik E, Stovner LJ, Schrader H, et al. Involvement of the renin-angiotensin system in migraine. J Hypertens Suppl. 2006 ; 24: S139 - S143